Schedule 13D ownership disclosure
Ventyx Biosciences Inc
Security class unavailable · CUSIP: 92332V107
Event date: 2022-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,252,432
- Percent of class
- 4.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000783
- Form type
- SC 13D
- Filer
- Third Point LLC
- CIK
- CIK 1040273
- Filed
- Nov 09, 2022
- Reporting period
- Nov 07, 2022
- Description
- Schedule 13D beneficial ownership